A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

NCT04851977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL: Respiratory Syncytial Vaccine
BIOLOGICAL: Respiratory Syncytial Vaccine
BIOLOGICAL: Placebo

Sponsor

Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.